Jason Lettmann, CEO of ALX Oncology Holdings Inc. ($ALXO), made two open market purchases totaling nearly $100,000 in the last year, with the most recent on September 17, 2025. These buys rank 2,350th among nearly 5,000 insiders, below the average of 1.5 million per person across 3.3 transactions. He also sold shares once for $1,525 on August 15, 2025, ranking 11,525th among nearly 12,000 insiders, well under the average of 8.6 million across 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | S | Common Stock | 12311 | $2.17 | 293,609.0000 | 54,218,001 | 4.02% | 0.02% |
| Feb. 17, 2026 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | F | Common Stock | 2201 | $2.27 | 305,920.0000 | 54,218,001 | 0.71% | 0.00% |
| Jan. 26, 2026 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | A | Stock option (right to buy) | 912000 | $0.00 | 912,000.0000 | 54,218,001 | 9999.99% | 1.68% |
| Oct. 14, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 597500 | $0.00 | 597,500.0000 | 53,384,145 | 9999.99% | 1.12% |
| Sept. 16, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | P | Common Stock | 21070 | $1.07 | 233,958.0000 | 53,384,145 | 9.90% | 0.04% |
| Sept. 17, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | P | Common Stock | 71163 | $1.08 | 305,121.0000 | 53,384,145 | 30.42% | 0.13% |
| Aug. 15, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | S | Common Stock | 2382 | $0.64 | 212,888.0000 | 53,384,145 | 1.11% | 0.00% |
| April 11, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 53,384,145 | 9999.99% | 0.23% |
| March 14, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | A | Common Stock | 42000 | $0.00 | 212,270.0000 | 53,384,145 | 24.67% | 0.08% |
| Feb. 19, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | S | Common Stock | 2159 | $1.15 | 170,270.0000 | 0 | 1.25% | 0.00% |
| Jan. 21, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 478000 | $0.00 | 478,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | F | Common Stock | 2191 | $2.58 | 169,429.0000 | 0 | 1.28% | 0.00% |
| March 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | P | Common Stock | 4400 | $11.31 | 171,620.0000 | 0 | 2.63% | 0.00% |
| Feb. 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | A | Employee Stock Option | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Lettmann Jason | CHIEF EXECUTIVE OFFICER | A | Common Stock | 60000 | $0.00 | 167,220.0000 | 0 | 55.96% | 0.00% |